We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Cello Health Plc | LSE:CLL | London | Ordinary Share | GB00B0310763 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 161.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMCLL
RNS Number : 4535X
Cello Group plc
21 February 2017
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) -------------------------------------------------------------------------------- 1. Identity of the issuer or CELLO GROUP PLC the underlying issuer of existing shares to which voting rights are attached: (ii) ------------------------------------------------------ ------------------------ 2 Reason for the notification (please tick the appropriate box or boxes): -------------------------------------------------------------------------------- An acquisition or disposal of voting rights ------------------------------------------------------- ----------------------- An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached ------------------------------------------------------- ----------------------- An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments ------------------------------------------------------- ----------------------- An event changing the breakdown of voting rights ü ------------------------------------------------------- ----------------------- Other (please specify): ----------------------------------------------------- ----------------------- 3. Full name of person(s) HARGREAVE HALE LIMITED subject to the notification obligation: (iii) ------------------------------------------------------ ------------------------ 4. Full name of shareholder(s) DISCRETIONARY CLIENTS (if different from 3.):(iv) ------------------------------------------------------ ------------------------ 5. Date of the transaction 20 FEBRUARY 2017 and date on which the threshold is crossed or reached: (v) ------------------------------------------------------ ------------------------ 6. Date on which issuer 21 FEBRUARY 2017 notified: ------------------------------------------------------ ------------------------ 7. Threshold(s) that is/are crossed or reached: (vi, vii) 5% ------------------------------------------------------ ------------------------ 8. Notified details: ------------------------------------------------------------------------------------------------------------------------ A: Voting rights attached to shares (viii, ix) ------------------------------------------------------------------------------------------------------------------------ Class/type Situation previous Resulting situation after the of to the triggering triggering transaction shares transaction if possible using the ISIN CODE ------------- -------------------------------- ----------------------------------------------------------------------- Number Number Number Number of % of voting of of of shares voting rights (x) Shares Voting rights Rights ------------- --------------- --------------- ------------------------- ------------------------ ------------------ Direct Indirect Direct Indirect Direct Indirect (xi) (xii) ------------- ----------- ----------- ----------- ------------ ---------- ------------ ------- --------- GB00B0310763 4,889,464 4,889,464 4,889,464 4,889,464 4.7451% --------------- --------------- ----------- ------------ ---------- ------------ ------- --------- B: Qualifying Financial Instruments ------------------------------------------------------------------------------------------------------------------------ Resulting situation after the triggering transaction ------------------------------------------------------------------------------------------------------------------------ Type of Expiration Exercise/ Number of voting % of voting financial date Conversion rights that rights instrument (xiii) Period (xiv) may be acquired if the instrument is exercised/ converted. ----------------- --------------- -------------------------- ------------------------------------ ------------------ C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi) ------------------------------------------------------------------------------------------------------------------------ Resulting situation after the triggering transaction ------------------------------------------------------------------------------------------------------------------------ Type of Exercise Expiration Exercise/ Number of voting % of voting financial price date Conversion rights instrument rights (xix, instrument (xvii) period refers to xx) (xviii) --------------- --------------- ------------- ----------- -------------------------- ------------------------------ Nominal Delta --------------- --------------- ------------- ----------- -------------------------- ------------------- --------- Total (A+B+C) ------------------------------------------------------------------------------------------------------------------------ Number of voting rights Percentage of voting rights ------------------------------------------------------------ ---------------------------------------------------------- 4,889,464 4.7451% ------------------------------------------------------------ ---------------------------------------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: (xxi) ------------------------------------------------------------------------------------------------------- 4,685,464 of these shares are held for a unit trust operated by Marlborough Fund Managers Ltd, for whom Hargreave Hale Ltd manages the investments on a discretionary basis. The remaining balance is held on behalf of other discretionary clients. Proxy Voting: ------------------------------------------------------------------------------------------------------- 10. Name of the proxy holder: ---------------------------------------------------------------- ------------------------------------- 11. Number of voting rights proxy holder will cease to hold: ---------------------------------------------------------------- ------------------------------------- 12. Date on which proxy holder will cease to hold voting rights: ---------------------------------------------------------------- ------------------------------------- The change in the percentage 13. Additional information: of shares held is due entirely to the placing by Cello Group Plc, the shares from which were admitted to AIM on 20/02/2017. ---------------------------------------------------------------- ------------------------------------- 14. Contact name: David Clueit, Hargreave Hale Ltd ---------------------------------------------------------------- ------------------------------------- 15. Contact telephone number: 01253 754739 ---------------------------------------------------------------- -------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLBXGDDIDDBGRB
(END) Dow Jones Newswires
February 21, 2017 08:30 ET (13:30 GMT)
1 Year Cello Health Chart |
1 Month Cello Health Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions